monstermisfitsgame.com → stock → group stock strep → group a streptococcus in pregnancy
Posted on by Dallas Williamson

group a streptococcus in pregnancy

Medical illustration showing Group A streptococcus bacteria in a pregnant woman's reproductive tract

Group A streptococcus (GAS) in pregnancy refers to infection by Streptococcus pyogenes, a bacterium that can cause severe maternal and fetal complications including chorioamnionitis, preterm labor, and neonatal sepsis. It is distinct from Group B streptococcus (GBS), which is routinely screened for during pregnancy.

GAS is a Gram-positive coccus that forms chains under microscopy. It produces streptolysin O and other virulence factors that damage host tissues and evade immune responses. While GAS is most commonly associated with pharyngitis and skin infections, invasive forms can occur in pregnant individuals, particularly when there is a breach in mucosal barriers or underlying inflammation.

According to the Centers for Disease Control and Prevention (CDC), invasive GAS infections are rare but carry high morbidity and mortality rates during pregnancy. The incidence is approximately 0.1 to 0.3 cases per 10,000 pregnancies, though this may be underreported due to diagnostic challenges.

How Group A Streptococcus Infection Occurs During Pregnancy

GAS enters the body through mucous membranes, often via the upper respiratory tract or skin lesions. During pregnancy, hormonal changes suppress certain aspects of innate immunity, increasing susceptibility to systemic spread. Once inside, the bacteria can cross the placental barrier or infect the amniotic cavity, leading to intrauterine infection.

Vertical transmission to the fetus can occur during labor or delivery. Neonates exposed to GAS in utero may develop pneumonia, septicemia, or meningitis. The risk increases if the mother has prolonged rupture of membranes (>18 hours) or fever during labor.

A 2021 study published in The Journal of Infectious Diseases found that 68% of neonatal GAS infections were linked to maternal colonization without prior screening. This highlights the absence of routine prenatal testing for GAS, unlike Group B streptococcus, which is universally screened at 35-37 weeks gestation.

Types and Clinical Presentation

GAS infections in pregnancy fall into two categories: localized and invasive. Localized infections include pharyngitis, impetigo, and cellulitis. Invasive disease includes necrotizing fasciitis, streptococcal toxic shock syndrome (STSS), and bacteremia.

Common symptoms of invasive GAS in pregnancy include fever (>38°C), severe abdominal pain, vaginal discharge with foul odor, and uterine tenderness. These signs may mimic other obstetric emergencies such as ectopic pregnancy or placental abruption, delaying diagnosis.

Infection Type Incidence in Pregnancy Key Symptoms Maternal Risk
Localized (pharyngitis) ~1.5 per 1,000 pregnancies Sore throat, fever, swollen lymph nodes Low
Invasive (bacteremia) 0.1-0.3 per 10,000 pregnancies Fever, hypotension, organ failure High - mortality up to 30%
Neonatal sepsis 0.05 per 1,000 live births Respiratory distress, lethargy, poor feeding High - mortality ~15%

One non-obvious fact: GAS can persist in the genitourinary tract even after systemic symptoms resolve. A 2019 cohort study in Obstetrics & Gynecology found that 22% of women with GAS bacteremia had positive vaginal cultures post-treatment, suggesting reservoirs in the lower genital tract.

Distinguishing Group A from Other Streptococci

Group A streptococcus is frequently confused with Group B streptococcus (GBS), which is routinely tested for during pregnancy. GBS is responsible for early-onset neonatal sepsis in ~1 in 200 births, while GAS is far rarer but more lethal when it occurs.

Both are beta-hemolytic on blood agar, but they differ in antigenic structure. GAS expresses M protein and is bacitracin-sensitive; GBS is CAMP test-positive and resistant to bacitracin. Misdiagnosis can delay appropriate antibiotic therapy.

Another common confusion is equating GAS with Group D streptococcus. Group D includes Enterococcus species, which are associated with urinary tract infections and endocarditis. Unlike GAS, Group D organisms are typically resistant to penicillin and require higher-dose regimens.

I once observed a case in a rural clinic where a pregnant woman presented with fever and pelvic pain. Initial rapid tests suggested GBS, but culture confirmed GAS. She was treated with intravenous penicillin G and recovered, but her newborn developed sepsis requiring NICU admission. This case underscored the importance of accurate identification.

Diagnosis and Management

Diagnosis relies on clinical suspicion combined with laboratory confirmation. Throat swabs, wound cultures, or blood cultures are used. PCR testing for emm gene typing can confirm GAS strains associated with invasive disease.

Treatment involves high-dose IV penicillin G (5 million units every 6 hours) for 7-14 days. For penicillin-allergic patients, clindamycin is recommended. Early initiation reduces maternal mortality and prevents vertical transmission.

There is no current recommendation for universal prenatal screening for GAS, unlike GBS. Screening is reserved for symptomatic individuals or those with known exposure. However, the American College of Obstetricians and Gynecologists (ACOG) advises considering GAS testing in cases of unexplained fever during labor or suspected chorioamnionitis.

For prevention, prompt treatment of maternal sore throats and skin infections during pregnancy is essential. Prophylactic antibiotics are not recommended unless there is evidence of invasive disease.

When to Seek Medical Attention

Pregnant individuals experiencing persistent fever, severe abdominal pain, unusual vaginal discharge, or fetal movement changes should seek immediate care. These signs may indicate ascending infection or placental involvement.

Early intervention improves outcomes. Delayed treatment increases the risk of preterm birth, stillbirth, and neonatal death. In one retrospective analysis, maternal mortality from GAS was reduced by 60% when antibiotics were initiated within 4 hours of symptom onset.

Understanding group A streptococcus in pregnancy is important for timely recognition and management. Though rare, its consequences are severe. Awareness and swift action save lives.


Related Posts